Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

Specimen Handling 84Magnetic Resonance Spectroscopy 83Cyclophosphamide 77pembrolizumab 64Radiotherapy 58Nivolumab 55fludarabine 47Cisplatin 45Biopsy 41Carboplatin 40Standard of Care 36Dexamethasone 33Rituximab 30Radiation 30Bevacizumab 30Radiosurgery 29Temozolomide 28Gemcitabine 28Surveys and Questionnaires 27Doxorubicin 27Cytarabine 27Paclitaxel 26venetoclax 25fludarabine phosphate 25Blood Specimen Collection 25Practice Guidelines as Topic 24Ipilimumab 24Interviews as Topic 21Fluorouracil 21atezolizumab 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Meropenem × 30 days × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡